Cinotti R, Lascarrou JB, Azais MA, Colin G, Quenot JP, Mahé PJ, Roquilly A, Gaultier A, Asehnoune K, Reignier J (2021) Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind, IRIHS study. Crit Care 25:98. https://doi.org/10.1186/s13054-021-03509-5

Article  PubMed  PubMed Central  Google Scholar 

Côté JM, Bouchard J, Murray PT, Beaubien-Souligny W (2021) Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: a retrospective study from the MIMIC-III database. J Crit Care 65:282–291. https://doi.org/10.1016/j.jcrc.2021.06.009

Article  PubMed  Google Scholar 

Imamura T, Kinugawa K (2019) Update of acute and long-term tolvaptan therapy. J Cardiol 73:102–107. https://doi.org/10.1016/j.jjcc.2018.10.003

Article  PubMed  Google Scholar 

Jujo K, Saito K, Ishida I, Furuki Y, Kim A, Suzuki Y, Sekiguchi H, Yamaguchi J, Ogawa H, Hagiwara N (2016) Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. ESC Heart Fail 3:177–188. https://doi.org/10.1002/ehf2.12088

Article  PubMed  PubMed Central  Google Scholar 

Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204. https://doi.org/10.1186/cc11454

Article  PubMed  PubMed Central  Google Scholar 

Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K (2014) Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J 78:844–852

Article  PubMed  Google Scholar 

Kinugawa K, Sato N, Inomata T (2018) Effects of tolvaptan on volume overload in patients with heart failure. Int Heart J 59:1368–1377. https://doi.org/10.1536/ihj.18-119

Article  PubMed  Google Scholar 

Kinugawa K, Sato N, Inomata T, Yasuda M, Shimakawa T, Fukuta Y (2019) Real-world effectiveness and tolerability of tolvaptan in patients with heart failure - final results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) study. Circ J 83:1520–1527. https://doi.org/10.1253/circj.CJ-19-0158

Article  PubMed  Google Scholar 

Kishimoto Y, Nakamura Y, Harada S, Onohara T, Kishimoto S, Kurashiki T, Fujiwara Y, Nishimura M (2018) Can tolvaptan protect renal function in the early postoperative period of cardiac surgery? - Results of a single-center randomized controlled study. Circ J 82:999–1007. https://doi.org/10.1253/circj.CJ-17-0967

Article  PubMed  Google Scholar 

Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297:1319–1331. https://doi.org/10.1001/jama.297.12.1319

Article  PubMed  Google Scholar 

Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA (2020) Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol 16:51–64. https://doi.org/10.1038/s41581-019-0191-y

Article  PubMed  Google Scholar 

L’Heureux M, Sternberg M, Brath L, Turlington J, Kashiouris MG (2020) Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep 22:35. https://doi.org/10.1007/s11886-020-01277-2

Article  PubMed  PubMed Central  Google Scholar 

Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR (2016) Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. J Card Fail 22:423–432. https://doi.org/10.1016/j.cardfail.2016.02.007

Article  PubMed  Google Scholar 

Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T (2007) Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials. Cardiovasc Drug Rev 25:1–13. https://doi.org/10.1111/j.1527-3466.2007.00001.x

Article  PubMed  Google Scholar 

Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G (2019) Estimated GFR: time for a critical appraisal. Nat Rev Nephrol 15:177–190. https://doi.org/10.1038/s41581-018-0080-9

Article  PubMed  Google Scholar 

Shen Y, Zhang W, Shen Y (2019) Early diuretic use and mortality in critically ill patients with vasopressor support: a propensity score-matching analysis. Crit Care 23:9. https://doi.org/10.1186/s13054-019-2309-9

Article  PubMed  PubMed Central  Google Scholar 

Wichmann S, Barbateskovic M, Liang N, Itenov TS, Berthelsen RE, Lindschou J, Perner A, Gluud C, Bestle MH (2022) Loop diuretics in adult intensive care patients with fluid overload: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Ann Intensive Care 12:52. https://doi.org/10.1186/s13613-022-01024-6

Article  PubMed  PubMed Central  Google Scholar 

Wilcox CS, Testani JM, Pitt B (2020) Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension 76:1045–1054. https://doi.org/10.1161/hypertensionaha.120.15205

Article  PubMed  Google Scholar